These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38588490)

  • 1. Nα-Aroyl-N-Aryl-Phenylalanine Amides: A Promising Class of Antimycobacterial Agents Targeting the RNA Polymerase.
    Seidel RW; Goddard R; Lang M; Richter A
    Chem Biodivers; 2024 Jun; 21(6):e202400267. PubMed ID: 38588490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro Metabolic Stability of Sterically Shielded Antimycobacterial Phenylalanine Amides.
    Lang M; Ganapathy US; Mann L; Seidel RW; Goddard R; Erdmann F; Dick T; Richter A
    ChemMedChem; 2024 Mar; 19(6):e202300593. PubMed ID: 38329388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-Spectrum In Vitro Activity of
    Lang M; Ganapathy US; Abdelaziz R; Dick T; Richter A
    Antibiotics (Basel); 2024 Apr; 13(5):. PubMed ID: 38786132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition.
    Lin W; Mandal S; Degen D; Liu Y; Ebright YW; Li S; Feng Y; Zhang Y; Mandal S; Jiang Y; Liu S; Gigliotti M; Talaue M; Connell N; Das K; Arnold E; Ebright RH
    Mol Cell; 2017 Apr; 66(2):169-179.e8. PubMed ID: 28392175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity.
    Franz ND; Belardinelli JM; Kaminski MA; Dunn LC; Calado Nogueira de Moura V; Blaha MA; Truong DD; Li W; Jackson M; North EJ
    Bioorg Med Chem; 2017 Jul; 25(14):3746-3755. PubMed ID: 28545813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
    Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
    Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
    Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides.
    Sriram D; Yogeeswari P; Devakaram RV
    Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-(Piperidin-3-yl)thymine amides as inhibitors of
    Jian Y; Risseeuw MDP; Froeyen M; Song L; Cappoen D; Cos P; Munier-Lehmann H; van Calenbergh S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1730-1739. PubMed ID: 31822127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of antituberculosis agents.
    Jones PB; Parrish NM; Houston TA; Stapon A; Bansal NP; Dick JD; Townsend CA
    J Med Chem; 2000 Aug; 43(17):3304-14. PubMed ID: 10966749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
    Mori G; Orena BS; Franch C; Mitchenall LA; Godbole AA; Rodrigues L; Aguilar-Pérez C; Zemanová J; Huszár S; Forbak M; Lane TR; Sabbah M; Deboosere N; Frita R; Vandeputte A; Hoffmann E; Russo R; Connell N; Veilleux C; Jha RK; Kumar P; Freundlich JS; Brodin P; Aínsa JA; Nagaraja V; Maxwell A; Mikušová K; Pasca MR; Ekins S
    Tuberculosis (Edinb); 2018 Sep; 112():98-109. PubMed ID: 30205975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides.
    Servusová B; Vobicková J; Paterová P; Kubíček V; Kuneš J; Doležal M; Zitko J
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3589-91. PubMed ID: 23659859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues.
    Jeankumar VU; Renuka J; Kotagiri S; Saxena S; Kakan SS; Sridevi JP; Yellanki S; Kulkarni P; Yogeeswari P; Sriram D
    ChemMedChem; 2014 Aug; 9(8):1850-9. PubMed ID: 24962352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
    Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antimycobacterial and cytotoxic activity of α,β-unsaturated amides and 2,4-disubstituted oxazoline derivatives.
    Avalos-Alanís FG; Hernández-Fernández E; Carranza-Rosales P; López-Cortina S; Hernández-Fernández J; Ordóñez M; Guzmán-Delgado NE; Morales-Vargas A; Velázquez-Moreno VM; Santiago-Mauricio MG
    Bioorg Med Chem Lett; 2017 Feb; 27(4):821-825. PubMed ID: 28117200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents.
    Fan YL; Wu JB; Ke X; Huang ZP
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.
    Lee RE; Hurdle JG; Liu J; Bruhn DF; Matt T; Scherman MS; Vaddady PK; Zheng Z; Qi J; Akbergenov R; Das S; Madhura DB; Rathi C; Trivedi A; Villellas C; Lee RB; Rakesh ; Waidyarachchi SL; Sun D; McNeil MR; Ainsa JA; Boshoff HI; Gonzalez-Juarrero M; Meibohm B; Böttger EC; Lenaerts AJ
    Nat Med; 2014 Feb; 20(2):152-158. PubMed ID: 24464186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
    Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.